Systemic Therapy Options for Unresectable and Metastatic Chordomas
β Scribed by Silvia Stacchiotti; Paolo Giovanni Casali
- Book ID
- 107546821
- Publisher
- Current Science Inc.
- Year
- 2011
- Tongue
- English
- Weight
- 163 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1523-3790
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Clinical trials evaluating systemic therapies for hepatocellular carcinomas (HCCs) must take into consideration prognostic factors that influence survival. Clinical features such as poor performance status, older age, and the presence of jaundice may be predictive of short survivals. Because patient
## Abstract A proliferation of new cytotoxic and biologic agents has led to improved survival in patients with metastatic colorectal cancer (mCRC). The ability of surgery to increase longβterm survival in patients with liver and/or lung metastases also has been firmly established. It has become inc